Since its inception 20 years ago, the National Institute for Health and Care Excellence (NICE) has established itself as a landmark in innovative healthcare technologies and the access to them. Indicative of the enormous interest in the experience of this organization is the existence of a special department for international cooperation, whose aim is to provide consultancy and expertise. Regulatory agencies around the world are closely following NICE’s decisions. A positive or negative opinion can predetermine patient access and clinical practice far beyond the UK. Almost at the very center of innovation in medicine and healthcare, in 2019 NICE announced that it would review and update its methodology for evaluating health technologies. For more information click here.
Rare Diseases and Orphan Drugs